CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers

Background: CCL19 is a chemokine involved in cancer research due to its important role in the tumor microenvironment (TME) and clinical relevance in cancers. This study aimed to analyze transcription expression, genomic alteration, association with tumor immune microenvironment of CCL19 expression a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Qiang, Zhou, Shifang, Chen, Cong, Wang, Zhi, Xu, Wenhao, Zhang, Jiarong, Wei, Shiyin, Yang, Jianfeng, Chen, Hongjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683612/
https://www.ncbi.nlm.nih.gov/pubmed/37944262
http://dx.doi.org/10.18632/aging.205184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683612/
https://www.ncbi.nlm.nih.gov/pubmed/37944262
http://dx.doi.org/10.18632/aging.205184

Ejemplares similares